Product Images Sildenafil Citrate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Sildenafil Citrate NDC 70518-1641 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

This is a description of Sildenafil, a prescription-only medication. It includes a National Drug Code, expiration date, and lot number, as well as the manufacturer's name and location. It also provides instructions for use and storage, and warns against keeping the medication out of the reach of children. It was repackaged by a company called RemedyRepack Inc.*

chemical structure

chemical structure

figure 1

figure 1

This appears to be a chart showing the Systolic Blood Pressure (mmHg) at different times after taking either SILDENAFL 100mg or a placebo. However, without more context it is difficult to provide further information or analysis.*

figure 2

figure 2

This is a chart that shows the change in systolic blood pressure (SBP) in mmHg over time (5-7 hours) after taking either Doxazosin and Placebo or Doxazosin and Sildenafil 25mg. The values on the y-axis range from 20 to 2 in increments of 2. The chart has two lines, one for each treatment group, and the x-axis shows the elapsed time (in hours) since the medication was taken.*

figure 3

figure 3

This is a table displaying the change in SBP (systolic blood pressure) in mmHG for two different interventions (Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg) at different time points post-dose (in hours). The values for change in SBP are 40 mmHG and 30 mmHG, respectively.*

figure 4

figure 4

This is a chart displaying the blood pressure in mmHg over time after taking either Doxazosin and Sildenafil 100mg, or Doxazosin and a placebo. The time after dosing is displayed on the x-axis while the blood pressure readings are on the y-axis. No other information is available.*

figure 5

figure 5

The text is describing a table or graph displaying plasma concentrations measured in ng/mL over time post-dose in hours for a treatment involving a commercial tablet identified as ©-6-6.*

figure 6 1

figure 6 1

figure 6 2

figure 6 2

figure 7

figure 7

This is a table that shows the percentage of patients reporting improvement after taking either placebo or different doses of sildenafil citrate, a medication used to treat erectile dysfunction. It includes data from a total of 463 patients taking placebo or different doses of sildenafil citrate (25mg, 50mg, and 100mg). The percentage of improvement was highest in the 100mg group (82%), followed by the 50mg group (74%), the 25mg group (63%), and the placebo group (24%).*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.